within Pharmacolibrary.Drugs.N_NervousSystem.N07A_Parasympathomimetics.N07AA51_NeostigmineCombinations;

model NeostigmineCombinations
  extends Pharmacolibrary.Drugs.ATC.N.N07AA51;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>N07AA51</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Neostigmine is a reversible acetylcholinesterase inhibitor used to enhance neuromuscular transmission. It is commonly used in the treatment of myasthenia gravis, reversal of non-depolarizing neuromuscular blockade post-surgery, and sometimes in the management of postoperative ileus and urinary retention. In combination products (ATC: N07AA51), it is typically combined with other cholinesterase inhibitors or anticholinergic agents. Neostigmine and its combinations are still approved for use today in many countries.</p><h4>Pharmacokinetics</h4><p>General adult population, both sexes, no specific disease or condition distinction, pharmacokinetic parameters derived primarily from pharmacokinetic studies in healthy volunteers with combination formulations.</p><h4>References</h4><ol><li><p>Morris, RB, et al., &amp; Fahey, MR (1981). Pharmacokinetics of edrophonium and neostigmine when antagonizing d-tubocurarine neuromuscular blockade in man. <i>Anesthesiology</i> 54(5) 399–401. DOI:<a href=\"https://doi.org/10.1097/00000542-198105000-00009\">10.1097/00000542-198105000-00009</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7224209/\">https://pubmed.ncbi.nlm.nih.gov/7224209</a></p></li><li><p>Pihlajamäki, K, et al., &amp; Jaakkola, P (1986). Pharmacokinetics of atropine in children. <i>International journal of clinical pharmacology, therapy, and toxicology</i> 24(5) 236–239. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3733273/\">https://pubmed.ncbi.nlm.nih.gov/3733273</a></p></li><li><p>de Kam, PJ, et al., &amp; Peeters, PA (2013). Effect of sugammadex on QT/QTc interval prolongation when combined with QTc-prolonging sevoflurane or propofol anaesthesia. <i>Clinical drug investigation</i> 33(8) 545–551. DOI:<a href=\"https://doi.org/10.1007/s40261-013-0095-8\">10.1007/s40261-013-0095-8</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23824662/\">https://pubmed.ncbi.nlm.nih.gov/23824662</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end NeostigmineCombinations;
